Barclays’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
117,212
+76,629
| +189% | +$1.67M | ﹤0.01% | 2073 |
|
|
2025
Q1 | $751K | Sell |
40,583
-12,916
| -24% | -$239K | ﹤0.01% | 2610 |
|
|
2024
Q4 | $1.43M | Buy |
53,499
+11,977
| +29% | +$319K | ﹤0.01% | 2422 |
|
|
2024
Q3 | $976K | Buy |
41,522
+38,132
| +1,125% | +$896K | ﹤0.01% | 2635 |
|
|
2024
Q2 | $63K | Sell |
3,390
-10,818
| -76% | -$201K | ﹤0.01% | 3587 |
|
|
2024
Q1 | $254K | Buy |
+14,208
| New | +$254K | ﹤0.01% | 3211 |
|